The Hormone Cascade: How Cortisol Disrupts Everything Downstream
Most people think of hormone decline as a straight line — you get older, your hormones drop. The reality is more mechanistic and, importantly, more actionable. Hormonal dysregulation almost always starts with a single upstream disruptor: cortisol.
Cortisol is synthesized from pregnenolone, the same precursor that produces testosterone, estrogen, progesterone, and DHEA. When chronic stress drives cortisol output persistently high, the body shunts pregnenolone toward cortisol production — at the direct expense of sex hormones. This is often called "pregnenolone steal," though the mechanism is nuanced: it's primarily an ACTH-driven increase in cortisol synthesis that outcompetes the gonads, not a literal theft of substrate.
The downstream effects are predictable and measurable. Chronically elevated cortisol:
- →Suppresses LH and FSH pulsatility from the pituitary, reducing the gonadotropin signal that drives testosterone and estrogen production
- →Increases SHBG (sex hormone-binding globulin), binding free testosterone and rendering more of it biologically inactive
- →Impairs thyroid conversion — specifically, the conversion of T4 (inactive) to T3 (active), producing the functional hypothyroidism pattern that shows up as fatigue with normal TSH readings
- →Disrupts progesterone production in women, contributing to the luteal phase deficiency pattern and the anxiety/sleep disruption cluster of perimenopausal symptoms
Clinical Implication
A 2020 review in Frontiers in Endocrinology found that men with the highest salivary cortisol patterns had 37% lower free testosterone compared to low-cortisol controls, independent of age. Treating the cortisol driver first — before considering TRT — often normalizes free testosterone without exogenous hormones.
The practical implication: before you assume you need testosterone replacement, check your cortisol rhythm. A 4-point salivary cortisol test (morning, noon, afternoon, evening) costs under $100 and reveals whether you have a cortisol dysregulation pattern driving everything downstream. This is information most standard bloodwork misses entirely.
Testosterone in Men: What Free vs. Total Actually Means
Testosterone declines at a rate of roughly 1–2% per year after age 30 in most men — a figure well-established across large population cohorts including the Massachusetts Male Aging Study and the European Male Aging Study. By age 50, the average man has 25–30% less testosterone than he did at 25. By 70, that figure is 50% or more. The decline is real, measurable, and clinically significant.
But "testosterone" on a standard lab panel is almost always total testosterone, and total testosterone is not the number that matters most. Here's why:
Bound + free testosterone. Approximately 98% is bound — either tightly to SHBG (44–70%) or loosely to albumin (28–54%). Only the unbound fraction is biologically active.
Only 1–3% of total testosterone. This is the fraction available to enter cells and bind androgen receptors. This is what drives libido, muscle protein synthesis, mood, and cognitive sharpness.
Sex hormone-binding globulin rises with age, chronic stress, low-fat diets, and alcohol. As SHBG rises, free T falls — even when total T looks "normal." This is the hidden variable in most hormone panels.
A man can have a total testosterone of 600 ng/dL (technically "normal" by most lab reference ranges) and still have severely low free testosterone if his SHBG is elevated. This is extremely common in men over 45 who are symptomatic but told their labs are "fine." The fix requires understanding what's driving SHBG elevation — and addressing it directly before considering TRT.
SHBG is elevated by: low calorie intake, very low fat diets, chronic alcohol consumption, hyperthyroidism, liver disease, and high estradiol. Interventions that reliably lower SHBG include adequate dietary fat, zinc supplementation, resistance training, optimizing thyroid function, and — paradoxically — moderate amounts of testosterone itself.
Women in Perimenopause: Why Standard "Normal" Ranges Are Clinically Useless
Perimenopause is not a single event — it's a 4–10 year hormonal transition that typically begins in the early-to-mid 40s and ends at menopause (defined as 12 consecutive months without a menstrual period). During this window, the hormonal environment is not simply "declining" — it's wildly erratic, with estradiol levels fluctuating 20-fold in a single cycle, progesterone dropping precipitously in the luteal phase, and FSH and LH rising as the pituitary compensates for declining ovarian responsiveness.
The three core hormonal shifts of perimenopause:
FSH and LH — The Pituitary Alarm Signal
As ovarian reserve declines, the pituitary ramps up follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in an attempt to stimulate the remaining follicles. Rising FSH (above 10 IU/L in the follicular phase, rising above 25 IU/L by late perimenopause) is one of the earliest and most reliable markers of the transition. However: FSH fluctuates enormously cycle-to-cycle, meaning a single measurement is unreliable. Trend data across 3–6 months is far more informative.
Estradiol — Erratic Before It Declines
Counterintuitively, estradiol often spikes high during early perimenopause as the pituitary drives remaining follicles harder. Many perimenopausal women experience estrogen dominance symptoms — breast tenderness, heavier periods, bloating, mood swings — before they ever experience the low-estrogen symptoms of menopause. The "standard range" of 15–350 pg/mL in premenopausal women is so wide as to be diagnostically meaningless. What matters is the relationship between estradiol and progesterone — specifically the ratio.
Progesterone — The First to Fall
Progesterone declines well before estradiol does. As ovulatory cycles become irregular, the corpus luteum — which produces most luteal-phase progesterone — becomes less reliable. Low progesterone manifests as: anxiety, sleep fragmentation (particularly waking at 2–4 AM), heavier and more irregular periods, and the brain fog cluster that many perimenopausal women describe. Progesterone is almost never tested on standard hormone panels. It should be drawn on day 21 of the cycle (or 7 days post-ovulation).
The "Normal Range" Problem
Laboratory reference ranges are built from population averages. A perimenopausal woman experiencing debilitating hot flashes, insomnia, and cognitive decline can have labs that "look normal" because her values fall within the enormous range derived from women aged 18–55. The correct question isn't "Is this value within the reference range?" — it's "Is this value optimal for this woman at this stage of her hormonal transition?" This requires a clinician trained in functional hormonal assessment, not a routine checkup.
The 5 Lifestyle Interventions With the Strongest Evidence
Before considering any pharmaceutical intervention, these five approaches have robust evidence and are universally applicable to both men and women. They are ordered by effect size.
Sleep — The Non-Negotiable Foundation
A landmark study published in the Journal of the American Medical Association found that men sleeping 5 hours vs 8 hours for one week showed testosterone levels equivalent to someone 10–15 years older. The effect is dose-dependent and appears within days. Growth hormone, which peaks during slow-wave sleep, drives IGF-1 and directly supports testosterone synthesis. No supplement, no protocol, and no exogenous hormone can overcome chronic sleep deprivation. Fix sleep first — always.
Resistance Training — The Strongest Non-Pharmaceutical Intervention
Acute testosterone increases of 15–25% are consistently documented immediately post-resistance training in both men and women. More importantly, regular resistance training reduces SHBG, improves insulin sensitivity (which directly affects SHBG and estrogen metabolism in women), and increases androgen receptor density — making existing testosterone more effective. The protocol with the strongest evidence: compound movements (squat, deadlift, row), 70–85% of 1RM, 3–4 sets, 3x per week. Chronic cardio without resistance work is insufficient and can suppress testosterone through cortisol elevation.
Zinc + Vitamin D — The Two Micronutrient Deficiencies That Matter Most
Zinc is a cofactor in testosterone biosynthesis and is lost through sweat — making deficiency particularly common in active individuals. A 1996 study in Nutrition (Prasad et al.) found that zinc supplementation in marginally deficient men nearly doubled serum testosterone over 6 months. Vitamin D functions more as a hormone than a vitamin — its receptor is present in testicular Leydig cells and ovarian tissue. Men with serum 25-OH vitamin D above 30 ng/mL have significantly higher testosterone than deficient men. Target vitamin D: 50–70 ng/mL. Supplement if below 40 ng/mL. Standard dosing: 2,000–5,000 IU D3 with K2.
Stress Management — Cutting the Cortisol Tap
The HPA axis and HPG axis are in direct competition. Every chronic stressor — work pressure, relationship conflict, financial anxiety, over-training — elevates cortisol and suppresses gonadotropins. The most evidence-based cortisol-lowering interventions: mindfulness meditation (8-week MBSR reduces cortisol by 15–20% in multiple RCTs), HRV-biofeedback (coherent breathing at 5–6 breaths/minute activates vagal tone and suppresses cortisol acutely), and adaptogenic herbs (ashwagandha: 600mg/day reduced cortisol by 27% in a 2012 Indian Journal of Psychological Medicine RCT). Nature exposure, social connection, and adequate recovery between training sessions all measurably reduce HPA axis output.
Time-Restricted Eating — Insulin Sensitivity and SHBG
Hyperinsulinemia directly suppresses SHBG synthesis in the liver — meaning chronically elevated insulin translates into lower free sex hormones. Time-restricted eating (16:8 or even 14:10) improves insulin sensitivity, which in turn raises SHBG in insulin-resistant women with PCOS, lowers it in insulin-resistant men where high SHBG suppresses free T, and normalizes the estrogen-progesterone ratio in perimenopausal women. The mechanism is downstream insulin and IGF-1 sensitivity — not the fasting itself. A 12-week time-restricted eating intervention in overweight men raised free testosterone by 11% without any other intervention.
The Labs Your Doctor Actually Needs to Order
Standard annual bloodwork rarely includes the hormonal panel that gives you real information. Here is what to request — and what each marker tells you.
| Marker | Who | Optimal Range | Why It Matters |
|---|---|---|---|
| Free Testosterone | Men + Women | Men: 15–25 pg/mL Women: 1.0–2.2 pg/mL |
The biologically active fraction. More diagnostically meaningful than total T. |
| DHEA-S | Men + Women | 200–350 µg/dL (50+) | Adrenal reserve marker. Declines 80% from age 25 to 75. Converts to both testosterone and estrogen. |
| SHBG | Men + Women | 20–40 nmol/L | Governs how much total T is bioavailable. Rising with age is the primary driver of low free T in men with "normal" total T. |
| Estradiol (E2) | Men + Women | Men: 20–30 pg/mL Women: cycle-dependent |
Men need adequate estradiol for bone density, cardiovascular protection, and libido. Over-suppression during TRT is a clinical error. |
| Progesterone | Women | >8 ng/mL on day 21 | Confirms ovulation and adequate luteal phase. Rarely ordered. Critical for perimenopausal assessment. |
| LH + FSH | Men + Women | Varies by sex and cycle | Distinguishes primary (gonadal) from secondary (pituitary) hypogonadism. Essential for treatment selection. |
| IGF-1 | Men + Women | 150–250 ng/mL (40–60) | Growth hormone surrogate. Reflects anabolic drive, recovery capacity, and metabolic age. Declines with poor sleep and sedentary behavior. |
Ask your physician to include these on your annual labs. If they decline, direct-to-consumer lab services (Ulta Lab Tests, LabCorp Direct) allow you to order most of these without a physician order.
When to Consider TRT or HRT — and What to Ask an Endocrinologist
Testosterone replacement therapy (TRT) for men and hormone replacement therapy (HRT) for women are appropriate interventions for many people over 40 — but only after exhausting lifestyle optimization and only with proper clinical oversight. The conversation about whether to start requires honest answers to the following questions:
Questions for your endocrinologist or hormone specialist:
- →Has my free testosterone (not just total T) been measured via equilibrium dialysis — the gold-standard method? (Many labs calculate rather than measure free T, introducing significant error.)
- →Have we ruled out secondary causes of low testosterone — specifically high prolactin, thyroid dysfunction, or sleep apnea?
- →For men: What is your protocol for monitoring hematocrit, PSA, and estradiol on TRT? (These are the three critical monitoring markers for safety.)
- →For women considering HRT: Will you prescribe bioidentical hormones (17-beta estradiol + micronized progesterone) rather than synthetic progestins? The WHI study's cardiovascular risks were largely attributed to synthetic medroxyprogesterone acetate, not bioidentical progesterone.
- →What is your threshold for prescribing? What symptoms, combined with what lab values, constitute your treatment threshold?
The Cardiovascular Evidence on HRT
The 2022 NAMS Position Statement and the "timing hypothesis" research from Clarkson et al. strongly suggests that HRT initiated within 10 years of menopause — the "window of opportunity" — reduces cardiovascular risk rather than increasing it. Women who initiate HRT after age 60 or more than 10 years post-menopause see different risk profiles. The timing of initiation matters as much as the choice of formulation.
Thorne Research — NSF Certified Hormone Support
Thorne Research produces pharmaceutical-grade supplements used by professional sports teams and clinical practitioners. Their zinc bisglycinate, vitamin D/K2 complex, and ashwagandha are among the most rigorously tested formulations available without a prescription. NSF Certified for Sport — meaning what's on the label is actually in the bottle.